Skip Nav Destination
Issues
1 September 2024
-
Cover Image
Cover Image
Ionic fluxes and corresponding cell volume dynamics are established aspects of cell division. How calcium fluxes impact mitosis, though, is poorly understood, and studying how calcium fluxes modulate tumor cell proliferation may unveil novel therapeutic targets. In their study on page 852, Li and colleagues employed calcium and chloride imaging, electrophysiological, and immunohistochemical methods to interrogate how calcium fluxes affect proliferation in a glioblastoma cell line. The authors discovered that intracellular calcium flares occur in the transition from anaphase to telophase, activating calcium-dependent chloride channels. Subsequently, chloride fluxes promote cell swelling necessary to complete mitosis. The cover features a raster plot depicting calcium dye fluorescence in regions of interest over time. This study is also highlighted on page 785. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1541-7786
EISSN 1557-3125
Journal Archive
Molecular Cancer Research (2002-Present; volumes 1-current)
(ISSN 0008-5472) Published monthly since November, 2002.Cell Growth & Differentiation (1990-2002; volumes 1-13)
(ISSN 1044-9523) Published monthly 1990- September, 2002.Table of Contents
Highlights
Review
Cancer Genes and Networks
Cancer Research Resources
Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Raymond J. Kostlan; John T. Phoenix; Audris Budreika; Marina G. Ferrari; Neetika Khurana; Jae E. Choi; Kristin Juckette; Somnath Mahapatra; Brooke L. McCollum; Russell Moskal; Rahul Mannan; Yuanyuan Qiao; Donald J. Vander Griend; Arul M. Chinnaiyan; Steven Kregel
Cell Fate Decisions
Computational Biology
RNA Biology
Signal Transduction and Functional Imaging
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.